Presentation is loading. Please wait.

Presentation is loading. Please wait.

Correlation of change in H2 concentration (△H2) haemodynamics or laboratory parameters. Correlation of change in H2 concentration (△H2) haemodynamics or.

Published byゆきひら はやしもと Modified over 5 years ago

Similar presentations

Presentation on theme: "Correlation of change in H2 concentration (△H2) haemodynamics or laboratory parameters. Correlation of change in H2 concentration (△H2) haemodynamics or."— Presentation transcript:

1 Correlation of change in H2 concentration (△H2) haemodynamics or laboratory parameters.
Correlation of change in H2 concentration (△H2) haemodynamics or laboratory parameters. (A) ΔH2 was positively correlated with cardiac index (CI; r=0.285, p=0.003). (B) ΔH2 was negatively correlated with high-sensitivity troponin T (hsTnT; r =−0.324, p=0.001). (C) ΔH2 was negatively correlated with C-reactive protein (CRP; r=−0.240, p=0.012). Atsushi Shibata et al. Open Heart 2018;5:e000814 ©2018 by British Cardiovascular Society

Download ppt "Correlation of change in H2 concentration (△H2) haemodynamics or laboratory parameters. Correlation of change in H2 concentration (△H2) haemodynamics or."

Similar presentations

From: Assessment of the Accuracy of Procalcitonin to Diagnose Postoperative Infection after Cardiac Surgery Anesthes. 2007;107(2):232-238. doi:10.1097/01.anes.0000271871.07395.ad.

From: Assessment of the Accuracy of Procalcitonin to Diagnose Postoperative Infection after Cardiac Surgery Anesthes. 2007;107(2): doi: /01.anes ad.
Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)

Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)
Whiskers boxplot (5th–95th centile) representing the C-reactive protein concentration (mg/L) in samples with an infliximab (IFX) trough concentration above.

Whiskers boxplot (5th–95th centile) representing the C-reactive protein concentration (mg/L) in samples with an infliximab (IFX) trough concentration above.
OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.

OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.
MACE rate among CAD severity groups (total 0

MACE rate among CAD severity groups (total 0
P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Correlation between maximal workload as achieved during a physical exercise test (treadmill or bicycle; horizontal axis) and left superficial femoral artery.

Correlation between maximal workload as achieved during a physical exercise test (treadmill or bicycle; horizontal axis) and left superficial femoral artery.
Coronary revascularisation rate (total 5

Coronary revascularisation rate (total 5
Influence of possible intermediary variables on PR interval mean difference (95% CI) between HIV-infected (ART-naïve or ART-exposed) children and healthy.

Influence of possible intermediary variables on PR interval mean difference (95% CI) between HIV-infected (ART-naïve or ART-exposed) children and healthy.
OR (95% CI) for CHD associated with inflammatory markers in all participants and in subsets of non-users of statins or non-users of aspirin therapy. OR.

OR (95% CI) for CHD associated with inflammatory markers in all participants and in subsets of non-users of statins or non-users of aspirin therapy. OR.
Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.
Masashi Maeda et al. Heart Asia 2013;5:7-14

Masashi Maeda et al. Heart Asia 2013;5:7-14
(A) Correlation between SPWV and VPWV, dashed line = line of unity solid line = regression line (B) Bland-Altman plot of agreement between SPWV and VPWV.

(A) Correlation between SPWV and VPWV, dashed line = line of unity solid line = regression line (B) Bland-Altman plot of agreement between SPWV and VPWV.
(A) Illustration of the receiver operating characteristic (ROC) curve (discrimination) of the recalibrated model on the external validation set data. (A)

(A) Illustration of the receiver operating characteristic (ROC) curve (discrimination) of the recalibrated model on the external validation set data. (A)
Endothelial function at baseline and follow-up (responders in white bars and non-responders in black). Endothelial function at baseline and follow-up (responders.

Endothelial function at baseline and follow-up (responders in white bars and non-responders in black). Endothelial function at baseline and follow-up (responders.
High Sensitivity Troponin (hsTnT) : Result Interpretation Matrix*

High Sensitivity Troponin (hsTnT) : Result Interpretation Matrix*
HOMA calculations where glucose is mmol/L and insulin is mU/L

HOMA calculations where glucose is mmol/L and insulin is mU/L
Risk of mortality and fatal and nonfatal cardiovascular events in highest vs lowest quartiles for troponin T End point Relative risk 95% CI p Mortality.

Risk of mortality and fatal and nonfatal cardiovascular events in highest vs lowest quartiles for troponin T End point Relative risk 95% CI p Mortality.
Classification of left ventricular (LV) size by (A) LV internal diameter in diastole (LVIDD) according to LV end-diastolic volume index (LVEDVi), (B) LVIDD.

Classification of left ventricular (LV) size by (A) LV internal diameter in diastole (LVIDD) according to LV end-diastolic volume index (LVEDVi), (B) LVIDD.
(A) 1-year mortality in relation to estimated glomerular filtration rate (eGFR), age (n=47 636) and presence of diabetes mellitus (n=47 624). (A) 1-year.

(A) 1-year mortality in relation to estimated glomerular filtration rate (eGFR), age (n=47 636) and presence of diabetes mellitus (n=47 624). (A) 1-year.

Similar presentations

Ads by Google